Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622

Jingpeng Wang; Shuyuan Li; Gaofeng Zhang; Huihua Han

doi:10.1186/s40709-021-00145-6

Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622

J Biol Res (Thessalon). 2021 Jun 28;28(1):14. doi: 10.1186/s40709-021-00145-6.

Authors

Jingpeng Wang¹, Shuyuan Li², Gaofeng Zhang³, Huihua Han⁴

Affiliations

¹ Department of Anaesthesiology, The Chengyang People's Hospital, No.76 Zhengyang Road, Chengyang District, Qingdao, 266109, Shandong Province, China. wjpwjpwjpwang@163.com.
² Fever Clinic, The Chengyang People's Hospital, Qingdao, Shandong Province, China.
³ Department of Anaesthesiology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong Province, China.
⁴ Department of Anaesthesiology, The Chengyang People's Hospital, No.76 Zhengyang Road, Chengyang District, Qingdao, 266109, Shandong Province, China.

Abstract

Background: Sevoflurane (Sev), a commonly used volatile anesthetic, has been reported to inhibit the process of colorectal cancer (CRC). Circular RNAs (circRNAs) are revealed to participate in the pathogenesis of CRC. This study aims to reveal the mechanism of hsa_circ_0000231 in Sev-mediated CRC progression.

Methods: The expression of hsa_circ_0000231 and microRNA-622 (miR-622) was detected by quantitative real-time polymerase chain reaction (qRT-PCR). Protein level was determined by western blot analysis. Cell proliferation was investigated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), cell colony formation and DNA content quantitation assays. Cell apoptosis was detected by Annexin V-fluorescein isothiocyanate and propidium iodide double staining and caspase 3 activity assays. Cell migration and invasion were investigated by wound-healing and transwell invasion assays, respectively. The putative relationship between hsa_circ_0000231 and miR-622 was predicted by circular RNA Interactome online database, and identified by dual-luciferase reporter and RNA immunoprecipitation assays. The impacts of hsa_circ_0000231 on Sev-mediated tumor formation in vivo were presented by in vivo assay.

Results: Hsa_circ_0000231 expression was upregulated, while miR-622 was downregulated in CRC tissues and cells compared with control groups. Sev treatment decreased hsa_circ_0000231 expression, but increased miR-622 expression in CRC cells. Sev treatment suppressed cell proliferation, migration and invasion, and induced cell apoptosis. Hsa_circ_0000231 overexpression restored Sev-mediated CRC progression in vitro. Additionally, hsa_circ_0000231 acted as a sponge of miR-622, and miR-622 inhibitors reversed the impacts of hsa_circ_0000231 silencing on CRC process. Furthermore, Sev treatment inhibited tumor growth by regulating hsa_circ_0000231 in vivo.

Conclusion: Hsa_circ_0000231 attenuated Sev-aroused repression impacts on CRC development by sponging miR-622. This findings may provide an appropriate anesthetic protocol for CRC sufferers undergoing surgery.

Keywords: CRC; Sev; hsa_circ_0000231; miR-622.